Monthly paliperidone among new Japan recommendations
This article was originally published in Scrip
Executive Summary
Janssen Pharma's once-monthly intramuscular injection formulations of paliperidone palmitate have been recommended for approval in Japan as Xeplion for the maintenance treatment of schizophrenia.